• Sheikh, Sir Aziz
• Lyons, Ronan A.
• Sivakumaran, Shanya
• Adeloye, Davies
• Vasileiou, Eleftheria
• Akbari, Ashley
• Robertson, Chris
• Alsallakh, Mohammad
• Davies, Gwyneth
• Rudan, Igor

Abstract

<jats:title>Abstract</jats:title><jats:sec sec-type="background"><jats:title>Background</jats:title><jats:p>The COVID-19 pandemic and the ensuing implementation of control measures caused widespread societal disruption. These disruptions may also have affected community transmission and seasonal circulation patterns of endemic respiratory viruses.</jats:p></jats:sec><jats:sec sec-type="objective"><jats:title>Objective</jats:title><jats:p>We aimed to investigate the impact of COVID-19–related disruption on influenza-related emergency hospital admissions and deaths in Wales in the first 2 years of the pandemic.</jats:p></jats:sec><jats:sec sec-type="methods"><jats:title>Methods</jats:title><jats:p>A descriptive analysis of influenza activity was conducted using anonymized pathology, hospitalization, and mortality data from the Secure Anonymised Information Linkage Databank in Wales. The annual incidence of emergency hospitalizations and deaths with influenza-specific diagnosis codes between January 1, 2015, and December 31, 2021, was estimated. Case definitions of emergency hospitalization and death required laboratory confirmation with a polymerase chain reaction test. Trends of admissions and deaths were analyzed monthly and yearly. We conducted 2 sensitivity analyses by extending case definitions to include acute respiratory illnesses with a positive influenza test and by limiting admissions to those with influenza as the primary diagnosis. We also examined yearly influenza testing trends to understand changes in testing behavior during the pandemic.</jats:p></jats:sec><jats:sec sec-type="results"><jats:title>Results</jats:title><jats:p>We studied a population of 3,235,883 Welsh residents in 2020 with a median age of 42.5 (IQR 22.9–61.0) years. Influenza testing in Wales increased notably in the last 2 months of 2020, and particularly in 2021 to 39,720 per 100,000 people, compared to the prepandemic levels (1343 in 2019). The percentage of influenza admissions matched to an influenza polymerase chain reaction test increased from 74.8% (1890/2526) in 2019 to 85.2% (98/115) in 2021. However, admissions with a positive test per 100,000 population decreased from 17.0 in 2019 to 2.7 and 0.6 in 2020 and 2021, respectively. Similarly, deaths due to influenza with a positive influenza test per 100,000 population decreased from 0.4 in 2019 to 0.0 in 2020 and 2021. Sensitivity analyses showed similar patterns of decreasing influenza admissions and deaths in the first 2 years of the COVID-19 pandemic.</jats:p></jats:sec><jats:sec sec-type="conclusions"><jats:title>Conclusions</jats:title><jats:p>Nonpharmaceutical interventions to control COVID-19 were associated with a substantial reduction in the transmission of the influenza virus, with associated substantial reductions in hospital cases and deaths observed. Beyond the pandemic context, consideration should be given to the role of nonpharmaceutical community-driven interventions to reduce the burden of influenza.</jats:p></jats:sec>

Topics

• size-exclusion chromatography